Clinical Trial Update: Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease [Phase 1, Phase 2]

View source ↗

Summary

SY-201 ophthalmic solution completed Phase 1/Phase 2 trials in Dry Eye Disease, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• SY-201 Ophthalmic Solution (SY-201)

Snippet

Sponsor: Seinda Pharmaceutical Guangzhou Corporation | Conditions: Dry Eye Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-11-26